Compare OGN & GEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | GEO |
|---|---|---|
| Founded | 1923 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.9B |
| IPO Year | 2020 | 1996 |
| Metric | OGN | GEO |
|---|---|---|
| Price | $13.76 | $27.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $11.25 | ★ $39.00 |
| AVG Volume (30 Days) | 2.0M | ★ 2.1M |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.58% | N/A |
| EPS Growth | N/A | ★ 727.27 |
| EPS | ★ 0.95 | 0.65 |
| Revenue | ★ $6,216,000,000.00 | $2,263,420,000.00 |
| Revenue This Year | N/A | $13.78 |
| Revenue Next Year | $2.51 | $8.73 |
| P/E Ratio | ★ $14.48 | $41.37 |
| Revenue Growth | N/A | ★ 3.85 |
| 52 Week Low | $5.69 | $12.51 |
| 52 Week High | $13.83 | $33.17 |
| Indicator | OGN | GEO |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 36.68 |
| Support Level | $13.46 | $22.29 |
| Resistance Level | $13.77 | $32.56 |
| Average True Range (ATR) | 0.04 | 1.34 |
| MACD | -0.00 | -0.39 |
| Stochastic Oscillator | 34.78 | 19.75 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services. The company operates in U.S, Australia and South Africa.